OWC Pharmaceutical Research Corp.
OWCP
Rank in Stocks
#35146
OWC Pharmaceutical Research Corp., which operates through its subsidiary One... OWC Pharmaceutical Research Corp., which operates through its subsidiary One World Cannabis Ltd., primarily focuses on the research and development of cannabis-based medical products. The company is dedicated to developing cannabis-derived therapies for a variety of conditions, including multiple myeloma, psoriasis, post-traumatic stress disorder (PTSD), chronic pain, and fibromyalgia. It is also innovating with a cannabis soluble tablet delivery system. Furthermore, OWC Pharmaceutical extends its expertise by providing consulting services to both private companies and governmental agencies on international medical cannabis protocols and regulatory frameworks. Founded in 2008 as Dynamic Applications Corp., the company adopted its current name, OWC Pharmaceutical Research Corp., in December 2014. Its headquarters are located in Ramat Gan, Israel.
Share Price
$0.000001
Last synced: 2026-11-10
Market Cap
$232.58
Change (1 day)
-90.00%
Change (1 year)
-90.00%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade OWC Pharmaceutical Research Corp. (OWCP)
Category
Healthcare
EPS for OWC Pharmaceutical Research Corp. (OWCP)
EPS as of September 2019 TTM: $0.00
According to OWC Pharmaceutical Research Corp.'s latest financial reports, its current EPS (TTM) is $0.00. At the end of 2018 the company had an EPS of $-0.07, a decrease compared to its 2017 EPS of $-0.03.
EPS history for OWC Pharmaceutical Research Corp. from 2008 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | 0.00 | -97.57% |
| 2018 | $-0.07 | 120.70% |
| 2017 | $-0.03 | 32.49% |
| 2016 | $-0.02 | 15.61% |
| 2015 | $-0.02 | -78.89% |
| 2014 | $-0.10 | 477.98% |
| 2013 | $-0.02 | 205.45% |
| 2012 | $-0.01 | -64.05% |
| 2011 | $-0.02 | -97.22% |
| 2008 | $-0.55 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $6.03 | -354,800.00% |
DE
|
|
| $6.01 | -353,500.00% |
DE
|
|
| $1.53 | -90,270.59% |
JP
|
|
| $3.66 | -215,394.12% |
CH
|
|
| $0.45 | -26,570.59% |
IL
|
Questions about OWC Pharmaceutical Research Corp.'s earnings per share (EPS)
What is OWC Pharmaceutical Research Corp.'s earnings per share (EPS)?
OWC Pharmaceutical Research Corp.'s earnings per share (EPS) over the last twelve months is $0.00, as of Sep 2019.
What was OWC Pharmaceutical Research Corp.'s earnings per share (EPS) in 2018?
In 2018, OWC Pharmaceutical Research Corp.'s earnings per share (EPS) was $-0.07, compared with $-0.03 in 2017.
How has OWC Pharmaceutical Research Corp.'s earnings per share (EPS) changed since 2013?
From 2013 to 2018, OWC Pharmaceutical Research Corp.'s earnings per share (EPS) was highest in 2016 ($-0.02) and lowest in 2014 ($-0.10).
How does OWC Pharmaceutical Research Corp.'s earnings per share (EPS) compare with similar companies?
OWC Pharmaceutical Research Corp.'s earnings per share (EPS) ($0.00) is lower than that of all 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with $6.03.